Teva Pharmaceutical Industries Limited (TEVA)

New York Stock Exchange Consolidated Issue - New York Stock Exchange Consolidated Issue Delayed Price. Currency in USD
Add to watchlist
17.01-0.03 (-0.18%)
At close: 4:00PM EDT

17.05 +0.04 (0.24%)
After hours: 4:37PM EDT

People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue21,903,00019,652,00020,272,000
Cost of Revenue10,044,0008,296,0009,216,000
Gross Profit11,859,00011,356,00011,056,000
Operating Expenses
Research Development2,111,0001,525,0001,488,000
Selling General and Administrative5,096,0004,717,0005,078,000
Non Recurring2,498,0001,762,000539,000
Total Operating Expenses---
Operating Income or Loss2,154,0003,352,0003,951,000
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes2,154,0003,352,0003,951,000
Interest Expense1,330,0001,000,000313,000
Income Before Tax824,0002,352,0003,638,000
Income Tax Expense521,000634,000591,000
Minority Interest1,656,000158,00042,000
Net Income From Continuing Ops329,0001,588,0003,055,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income329,0001,588,0003,055,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares68,0001,573,0003,055,000